The patent on Lansoprazole (Zoton) has expired and generic versions are now available for several generic manufacturers. The price of these new versions is expected to fall over time.
The patent expiry will not affect the FastTabs because an additional patent on the formulation protects this product. Only generic prescriptions for capsules will be affected.
As recommended in the formulary, omeprazole remains the first line choice and lansoprazole makes a good second choice based on clinician experience and the new availability of a generic to drive the cost down.
Action: Clinicians should still use omeprazole as first line with lansoprazole capsules as second choice.